Indeed, recent studies have shown that YBX1 may have a critical role in leukemogenesis in non-infectious T-cell acute lymphoblastic leukemia (T-ALL) by regulating expression of the PI3K/AKT and ERK signaling pathways [73]. This evidence concerns the gene AKT1 and T-cell acute lymphoblastic leukemia.